AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech
- Posted on June 13, 2025
- By Financial Times
- 1 Views
AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech
Partnership gives group access to CSPC’s AI platform for discovering and optimising treatments
